Journal of the American Academy of Dermatology

Papers
(The H4-Index of Journal of the American Academy of Dermatology is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Table of Contents661
Comment on “Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case–control study from Denmark”206
Reply to: “Comment on ‘A novel anesthetic technique for palmar botulinum toxin injections’”191
Transcultural assessment of quality of life in patients with vitiligo176
Answers to CME examination158
JAAD Game Changer: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment136
JAAD Game Changer: Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study134
First, and foremost, a physician127
This Month in JAAD International: January 2023: Toward a more inclusive vision of cosmetic surgery125
Combined medical and surgical therapy for hidradenitis suppurativa121
Composite subcuticular subcutaneous buried suture119
Maintaining patient privacy119
Reply to Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia116
Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study110
A National cross-sectional survey of skin of color dermatology research fellowships: Structure and residency match outcomes107
JAAD Case Reports article list103
Patient-reported exacerbating factors for hidradenitis suppurativa: A cross sectional study102
Reviewers’ List December 2023100
Editorial board100
Establishing baselines of hair density measurements: Variations across ethnicity, scalp region, and measurement techniques: A systematic review99
CME examination92
Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study90
Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening86
Pediatric Game Changers∗: Cantharidin for treatment of facial molluscum contagiosum: A retrospective review86
Assessing the ethics of prior authorization denials and step therapy policies in dermatology85
Combination of acetaminophen and ibuprofen is noninferior to acetaminophen and hydrocodone for postnail procedure analgesia: A randomized controlled trial82
Biotin beware: Perils of biotin supplementation: Response to: “The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins”82
Utility of magnetic resonance imaging in the diagnosis of eosinophilic fasciitis: A multicenter retrospective cohort study81
Using plastic guards for better regulation of depth of punch biopsy instruments79
Gender analysis of publishing among medical students in dermatology78
Asynchronous telemedicine for isotretinoin management: A direct care pilot75
43168 Amyopathic Dermatomyositis: When Malignancy Is Lurking In The Shadows75
26589 Spesolimab, an IL-36R inhibitor, may reduce symptoms of pain in patients with palmoplantar pustulosis – Results from a small pilot study75
26945 Purpuric pressure ulcers in hospitalized patients with COVID-19: A case series73
26616 A comparison of case definitions for infant atopic dermatitis in a large multicenter study73
33505 Reddit and dermatology: Analyzing user-submitted posts seeking dermatologic advice on r/SkincareAddiction and r/DermatologyQuestions73
43976 Characterizing the Burden of Calciphylaxis: A Qualitative Analysis73
41310 Correlation between lactate dehydrogenase and total IgE levels, TARC levels, and eosinophil count in patients with atopic dermatitis73
43777 Cutting Edge Technology Without the Knife: Treating Skin Cancer in the 21st Century71
33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA268
25406 Comparison of biologic initiation and health care costs among patients with psoriasis receiving fixed-dose combination halobetasol-propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion vs calcipotr68
25602 Improvements and response achievement in PASI subscale domains for head scaling and erythema in apremilast-treated patients with moderate to severe plaque psoriasis of the scalp: Results from th66
32060 Evaluating provider perceptions and attitudes about the unique needs of older adult patients in dermatology clinics66
35412 Evaluating the risk in postoperative complications among patients with pre-existing hypothyroidism who underwent Mohs micrographic surgery65
40499 Psycho-cognitive Aspects of Disease Correlate Stronger with Quality of Life Impairment Compared to Objective Disease Severity64
32339 Expression of interleukin 36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene64
25894 CLL-associated cryofibrinogenemia62
33288 Hidradenitis suppurativa and dermatologic comorbidities in adults: A national-cross sectional study61
26271 M89, a combination of 89% Vichy volcanic mineralizing water and hyaluronic acid, is an effective adjunct to skin care in management of rosacea59
33965 Learn2Derm: A community-based pilot program assessing beliefs surrounding skin cancer risk factors, presentation, and prevention strategies59
26138 Clinical utility and reliability of buccal mucosal biopsies for the diagnosis of ocular cicatricial pemphigoid in patients with isolated ocular disease59
42780 A National Analysis of the Weekend Effect in Children Diagnosed with Dermatomyositis using the Kids’ Inpatient Database54
43346 Women Leadership in Dermatology: The Future is Female54
41464 A randomized, controlled study to assess effectiveness and safety of correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant53
43781 Evaluation of the miR-326 miRNA level in RDEB associated fibrosis53
44134 Long-Term Improvement in Difficult-To-Treat Areas and Quality of Life in Patients with Psoriasis Up to 204 Weeks Post Switch From Ustekinumab To Risankizumab53
33323 Dersimelagon, a melanocortin-1 receptor agonist, maintains efficacy regardless of seasons in subjects with erythropoietic protoporphyria: Results from a post hoc analysis of phase 2 clinical tri53
0.075546026229858